Beijing Labtech Instruments Co. Ltd. Class A

Beijing Labtech Instruments Co. Ltd. Class A

SSSE:688056
41.30
CNY
+3.38
(+8.91%)
0.44EPS
145.52P/E
4.35BMarket Cap
Oct 28Next Earn
Beijing Labtech Instruments Co. Ltd. Class A
SSE:688056
(Shanghai Stock Exchange)

Recent

price

41.30

P/E

ratio

145.52

div

yld

- -

ROIC.AI

2012
2013
2014
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
8.68
5.23
4.39
5.8
6.43
7.02
7.63
6.25
5.53
5.33
6.19
6.39
5.96
5.99
Revenue per Share
1.15
0.81
0.59
0.91
0.98
1.2
1.23
1.17
1.04
0.67
0.41
0.59
0.6
0.44
Basic EPS, GAAP
0.75
0.65
0.35
0.91
1.07
0.86
0.52
1.44
-0.43
-0.3
0.24
0.76
0.49
- -
Free Cash Flow per Basic Share
0.83
- -
0.36
0.07
0.87
- -
0.6
0.32
0.3
0.35
0.2
0.92
0.6
- -
Dividend per Share
2.13
2.78
3
4.63
4.64
5.91
6.53
11.05
11.74
12.3
12.63
12.12
12.01
11.97
Book Value per Share
1.95
2.6
2.82
4.1
3.93
5.3
5.78
10.51
11.21
11.74
12.06
11.7
11.64
11.61
Tangible Book Value per Share
22
40
50
50
50
50
50
56
67
67
67
66
67
67
Basic Weighted Avg Shares
189
212
218
290
322
350
381
349
369
355
416
424
401
399
Sales/Revenue/Turnover
15.8
18.53
16.57
16.71
21.15
20.26
19.24
20.63
18.81
12.94
6.81
11.4
10.25
7.86
Operating Margin (%)
2
3
4
4
4
5
5
5
7
9
14
16
16
- -
Depreciation Expense
25
33
29
46
49
60
61
65
69
45
28
39
40
30
Net Income, GAAP
19.69
18.62
19.83
14.6
21.24
14.28
16.26
14.55
15.26
12.83
3.07
10.49
12.41
9.17
Effective Tax Rate (%)
13.25
15.49
13.45
15.68
15.24
17.09
16.12
18.71
18.82
12.57
6.63
9.23
10.07
7.41
Profit Margin (%)
60
84
98
164
162
225
231
650
636
646
649
634
645
648
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
2
1
1
LT Debt
107
139
150
231
233
296
328
741
786
827
849
818
810
808
Total Equity
- -
23.67
19.29
21.74
20.67
20.4
19.37
11.01
8.55
5.54
3.29
4.7
4.99
3.6
Return on Invested Capital (%)
- -
26.68
20.28
23.17
21.09
22.58
19.31
12.11
9.09
5.54
3.29
4.69
4.96
3.61
Return on Capital (%)
- -
26.73
20.28
23.86
21.18
22.68
19.71
12.23
9.09
5.53
3.29
4.7
4.96
3.61
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
1
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
1
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
67
67
67
Market Capitalization
2,267
2,304
4,354

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
766
761
751
Cash, Cash Equivalents & STI
520
498
475
Accounts Receivable, Net
54
56
70
Inventories
177
187
178
Total Current Liabilities
121
110
103
Payables & Accruals
- -
- -
- -
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
22.81%
1.87%
-0.9%
Free Cash Flow
15.53%
-34.29%
-33.62%
Net Income, GAAP
7.16%
-4.46%
3.19%
Sales/Revenue/Turnover
6.9%
3.15%
-5.41%
Total Cash Common Dividend
- -
61.34%
-34.58%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
105
109
97
113
424
2025
99
93
- -
116
401
2026
87
103
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.17
0.18
0.17
0.06
0.59
2025
0.19
0.12
- -
0.12
0.6
2026
0.1
0.1
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
0.17
0.12
0.92
2025
- -
- -
- -
- -
0.6
2026
- -
- -
- -
- -
- -
Business
Beijing Labtech Instruments Co., Ltd. provides advanced laboratory products and comprehensive scientific solutions worldwide. As a global technology firm, it specializes in the research, development, and manufacturing of cutting-edge organic and inorganic sample preparation systems, precision temperature control equipment, and sophisticated analytical instruments like HPLC and UV-Vis spectrophotometers. The company also delivers integrated laboratory engineering services and essential consumables. Serving diverse sectors such as environmental monitoring, food safety, pharmaceuticals, and disease control, Labtech is committed to advancing global scientific analysis. The company is headquartered in Beijing, China.